---
annotations:
- type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Egonw
description: The 22 members of the fibroblast growth factor (FGF) family of growth
  factors mediate their cellular responses by binding to and activating the different
  isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
  FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
  processes in which cell fate and differentiation to various tissue lineages are
  determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
  sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
  that lead to the variety of cellular responses induced by this large family of growth
  factors. An alternative, FGF-independent, source of FGFR activation originates from
  the interaction with cell adhesion molecules, typically in the context of interactions
  on neural cell membranes and is crucial for neuronal survival and development.<br><br>Upon
  ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is
  activated causing phosphorylation of multiple tyrosine residues on the receptors.
  These then serve as docking sites for the recruitment of SH2 (src homology-2) or
  PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling
  enzymes. Signaling complexes are assembled and recruited to the active receptors
  resulting in a cascade of phosphorylation events.<br><br>This leads to stimulation
  of intracellular signaling pathways that control cell proliferation, cell differentiation,
  cell migration, cell survival and cell shape, depending on the cell type or stage
  of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654736
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3335
- /instance/WP3335
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3335.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The 22 members of the fibroblast growth factor (FGF) family of growth
    factors mediate their cellular responses by binding to and activating the different
    isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
    FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
    processes in which cell fate and differentiation to various tissue lineages are
    determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
    sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
    that lead to the variety of cellular responses induced by this large family of
    growth factors. An alternative, FGF-independent, source of FGFR activation originates
    from the interaction with cell adhesion molecules, typically in the context of
    interactions on neural cell membranes and is crucial for neuronal survival and
    development.<br><br>Upon ligand binding, receptor dimers are formed and their
    intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine
    residues on the receptors. These then serve as docking sites for the recruitment
    of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors,
    docking proteins or signaling enzymes. Signaling complexes are assembled and recruited
    to the active receptors resulting in a cascade of phosphorylation events.<br><br>This
    leads to stimulation of intracellular signaling pathways that control cell proliferation,
    cell differentiation, cell migration, cell survival and cell shape, depending
    on the cell type or stage of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654736
    Reactome].
  keywords:
  - 'FGF4 '
  - mutants and
  - 'SHC1-2 '
  - FGFR1OP-p-FGFR1
  - homodimer
  - PP2A(A:C):SPRY2
  - GRB2:GAB1
  - 'CPSF6-p-2Y-FGFR1 fusion '
  - FGFR1c P252X mutant
  - 'FGF1 '
  - 'PI(3,4,5)P3 '
  - p-STAT5A, p-STAT5B
  - P252X mutants
  - 'dovitinib '
  - 'TRIM24-p-2Y-FGFR1 fusion '
  - 'FGF17-1 '
  - 'FGF8-1 '
  - 'p-Y546,Y584-PTPN11 '
  - FGFR1:p-FRS3
  - FRS2
  - 'ZMYM2-p-2Y-FGFR1 fusion '
  - p-Y371-CBL:GRB2
  - FGFR1:p-FRS2:p-PTPN11:GRB2:GAB1:PI3K
  - fusions:PLCG1
  - 'BCR-p-FGFR1 fusion '
  - p-SPRY2:GRB2
  - GRB2-1:SOS1
  - PP2A (A:C)
  - FGFR1:p-FRS:p-PTPN11
  - 'STAT1 '
  - FGFR1:p-FRS2
  - 'UBC(457-532) '
  - 'PPP2CB '
  - 'p-Y699-STAT5B '
  - 'FGF2(10-155) '
  - 'STAT5B '
  - PP2A(A:C):S112/S121-pSPRY2
  - dimers
  - 'SPRED2 '
  - 'UBC(1-76) '
  - 'SPRY2 '
  - 'FGFR1b '
  - cascade
  - 'PPP2CA '
  - Activated
  - 'FGFR1 K656E '
  - Plasma membrane
  - FGFR1:p-FRS2:GRB2:GAB1:PIK3R1
  - KAL1:HS
  - 'UBC(77-152) '
  - 'GalNAc-T178-FGF23(25-251) '
  - 'p-Y-GAB2 '
  - 'FGFR1OP-p-FGFR1 fusion '
  - FGF23 bound to
  - 'FGFR1OP-FGFR1 fusion '
  - 'CBL '
  - 'p-S111,S120-SPRY2 '
  - inhibitors of FGFR1
  - FGFR:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1
  - 'p-8Y- FGFR1 R576W '
  - p-T,Y MAPK dimers
  - Ub-(Y55/Y227)p-SPRY2
  - RAF/MAP kinase
  - mutant:GRB2:GAB2
  - 'FGFR1 N546K '
  - signaling
  - 'GAB2 '
  - FGFR1:p-FRS2:GRB2:SOS1
  - STAT1, STAT3
  - 'UBB(77-152) '
  - GRB2:GAB1:PIK3R1
  - 'UBC(229-304) '
  - p-Y701-STAT1,
  - Klotho bound to
  - 'pY177-BCR-p-FGFR1 fusion '
  - 'FGFR1OP2-FGFR1 fusion '
  - 'CPSF6-FGFR1 fusion '
  - PP2A(A:C):Y55/Y227-pSPRY2
  - 'p-Y694-STAT5A '
  - 'UBC(305-380) '
  - homodimers
  - 'ERLIN2(1-185):FGFR1(c.-88-822) fusion '
  - 'LRRFIP1-FGFR1 fusion '
  - cytosolic p-FGFR1
  - 'FGFRL1 '
  - 'UBC(609-684) '
  - FGFR1c homodimer
  - 'SOS1 '
  - 'p-T202,Y204-MAPK3 '
  - 'UBC(533-608) '
  - Activated FGFR1:FRS3
  - KAL1
  - overexpressed FGFR1
  - FGFR1c
  - 'FGF10 '
  - mutant dimer
  - p-S111,S120-SPRY2
  - PTPN11
  - 'FGF6 '
  - 'UBB(153-228) '
  - FGFR1 mutants with
  - SPRED1/2 dimer
  - Activated FGFR1
  - FGFR1c P252X mutants
  - STAT5A,STAT5B
  - FGFR1:p-FRS2:p-PTPN11
  - 'STAT3 '
  - 'p-Y705-STAT3 '
  - bound to FGF
  - 'ERLIN2(1-185):p-8Y FGFR1(c.-88-822) fusion '
  - BRAF
  - FGFR1b-binding FGFs
  - p21 RAS:GDP
  - PPA2A (A:C):Y55/Y227
  - FGF23
  - Ub:Y55/Y227-pSPRY2:CBL
  - FGFR1:PLCG1
  - 'FGF9 '
  - 'p-6Y FGFR1(22-763):TACC1(571-805) fusion '
  - Activated FGFR1:FRS2
  - plasma membrane
  - 'FGF18 '
  - 'p-Y701-STAT1 '
  - 'GTP '
  - FGFR1:TKIs
  - enhanced kinase
  - 'SPRED1 '
  - FGFR1:p-4Y-PLCG1
  - Overexpressed FGFR1
  - 'ZMYM2-FGFR1 fusion '
  - 'CNTRL-p-2Y-FGFR1 fusion '
  - 'FRS3 '
  - Tyrosine kinase
  - 'UBB(1-76) '
  - Plasma membrane p-Y
  - 'PIK3CA '
  - pY177-BCR-p-FGFR1
  - dimer:SPRED1/2
  - 'p-Y239,Y240,Y317-SHC1-2 '
  - 'FLRT2 '
  - 'MYO18A-FGFR1 fusion '
  - 'S-Farn-Me KRAS4B '
  - p-FGFR1 fusion
  - 'cytosolic activated FGFR1 fusion mutants '
  - PPA2A(A:C):SPRY2
  - 'FGFR1 R576W '
  - FGFR1 mutant dimers
  - 'KAL1 '
  - PLCG1
  - FGFR1b
  - p-T250,T255,T385,S437-MKNK1
  - 'MYO18A-p-2Y-FGFR1 fusion '
  - mutant:GRB2:p-GAB2:PIK3R1
  - ATP
  - 'FGFR1c '
  - FLRT1,2,3
  - 'STAT5A '
  - 'BAG4(1-126):FGFR1(208-822) fusion '
  - FGFR1:p-8T-FRS2
  - GDP
  - Y55/Y227-pSPRY2:CBL
  - PIP3 activates AKT
  - 'p-8Y-FGFR1c P252R '
  - 'BAG4(1-126):p-8Y FGFR1(208-822) fusion '
  - cytosolic FGFR1
  - 'p-8Y-FGFR1 N546K '
  - 'GAB1 '
  - fusion:p-PLCG1
  - 'p-Y194,Y195,Y272-SHC1-3 '
  - 'HS '
  - 'CUX1-p-2Y-FGFR1 fusion '
  - 'S-Farn-Me PalmS NRAS '
  - SHC1-2,SHC1-3
  - dimers bound to
  - SRC-1
  - HS
  - mutant
  - FGFR1b homodimer
  - p-Y705-STAT3
  - Activated FGFR1:FLRT
  - pY177-BCR1-p-FGFR1
  - 'p-8Y-FGFR1c '
  - FGFR1:p-FRS
  - 'FGF20 '
  - FGFR1:p-FRS2:GRB2:GAB1:PI3K
  - dimer
  - PIK3R1
  - activated
  - 'p-8Y-FGFR1c P252T '
  - 'p-Y55,Y227-SPRY2 '
  - PI(3,4,5)P3
  - mutant:GRB2:p-GAB1:PI3K
  - Activated FGFR1c
  - 'p-Y371-CBL '
  - FGFRL1-binding
  - 'FGF22 '
  - 'p-S112,S115-SPRY2 '
  - pY177-BCR-pY-FGFR1
  - mutant:GRB2:p-GAB2
  - 'UBC(381-456) '
  - (A:C):S112/S115
  - DAG and IP3
  - S111/S120
  - 'BCR-FGFR1 fusion '
  - 'FGFR1c P252T '
  - 'FGF23(25-251) '
  - 'p-T185,Y187-MAPK1 '
  - 'p-8Y-FGFR1 K656E '
  - FGFs
  - 'GRB2-1 '
  - 'FGFR1c P252R '
  - 'KL-2 '
  - fusion mutant
  - 'FGF5-1 '
  - Ub
  - GRB2-1
  - 'BRAF '
  - 'RPS27A(1-76) '
  - 'FGF3 '
  - 'FRS2 '
  - 'S-Farn-Me-PalmS KRAS4A '
  - 'LRRFIP1-p-2Y-FGFR1 fusion '
  - 'TRIM24-FGFR1 fusion '
  - 'S-Farn-Me-2xPalmS HRAS '
  - with enhanced
  - GTP
  - FGFR1:p-FRS2:p-PTPN11:p-CBL:GRB2
  - PI(4,5)P2
  - p21 RAS:GTP
  - FGF23:Klotho
  - 'UBA52(1-76) '
  - mutant dimers with
  - FGFR1 fusions
  - overexpressed
  - fusion mutants
  - FGFRL1 dimer
  - FRS3
  - FGFR1c-binding FGFs
  - GRB2:GAB2
  - dimers:TKIs
  - 'p-6Y-FRS2 '
  - BCR-p-FGFR1 fusion
  - PIK3CA
  - FGFRL1
  - FGFR1:p-SHC1:GRB2:SOS1
  - PPA2A
  - Activated FGFR1:SHC1
  - 'FGFR1(22-763):TACC1(571-805) fusion '
  - 'GDP '
  - 'KL-1 '
  - FGFR1 fusion dimers
  - ADP
  - 'p-4Y-PLCG1 '
  - p-FGFR1 mutant
  - 'PPP2R1A '
  - FGFR1c:KAL1
  - FGFR1:p-FRS:PTPN11
  - fusion mutant dimer
  - 'CNTRL-FGFR1 fusion '
  - FGFRL1-binding FGFs
  - fusions:PI3K
  - p-SPRY2:B-RAF
  - 'p-8Y-FGFR1c P252S '
  - 'FGFR1OP2-p-2Y-FGFR1 fusion '
  - 'SHC1-3 '
  - mutants and fusions
  - 'FGFR1c P252S '
  - 'FLRT1 '
  - 'Activated FGFR1 mutants '
  - 'p-8T-FRS2 '
  - 'PIK3R1 '
  - Overexpressed
  - 'p-8Y-FGFR1b '
  - 'p-S112,S121-SPRY2 '
  - 'FLRT3 '
  - bound to
  - 'UBC(153-228) '
  - FGFs:FGFRL1 dimer
  - FGFR1:p-SHC1
  - complex:Ub-p-FRS2
  - dimers:PIK3R1
  - kinase activity
  - p-4Y-PLCG1
  - p-Y177-BCR-pY-FGFR1
  - SPRY2:B-RAF
  - 'PTPN11 '
  - 'p-5Y-FRS3 '
  - 'PLCG1 '
  - CBL
  - inhibitors of
  - FGFR1 fusion mutant
  - Klotho and FGFR1c
  - Pi
  - p-SPRY2
  - Ub-Activated FGFR1
  - 'CUX1-FGFR1 fusion '
  - activity
  - Activated FGFR1b
  license: CC0
  name: Signaling by FGFR1
seo: CreativeWork
title: Signaling by FGFR1
wpid: WP3335
---